Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Domain 8: Method of measurement of outcome
Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes
Retatrutide (LY3437943): Investigational Triple Agonist for Obesity & Metabolic Disease Current Status (February 2026): Investigational only
It was a signal
Altimmune Presents Data from Phase 2 MOMENTUM Trial of Pemvidutide in Obesity during Oral Presentation at the American Diabetes Association
While conclusive human studies are limited, excessive or prolonged use of IGF-1 or IGF1-LR3 should be avoided to minimize potential oncogenic effects
US$ 28.25
US$ 28.99
US$ 25.99
US$ 22.68
